Phyto Chem (India) Limited (BOM:524808)
India
· Delayed Price · Currency is INR 23.91
-0.09 (-0.37%)
At close: Mar 9, 2026
Phyto Chem (India) Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 102.95 | 140.78 | 148.11 | 267.6 | 231.19 | 444.88 | Upgrade
|
| Other Revenue | 15 | 15 | 20 | - | - | - | Upgrade
|
| Revenue | 117.95 | 155.78 | 168.11 | 267.6 | 231.19 | 444.88 | Upgrade
|
| Revenue Growth (YoY) | -29.83% | -7.33% | -37.18% | 15.75% | -48.03% | 0.60% | Upgrade
|
| Cost of Revenue | 98.33 | 116.49 | 130.85 | 180.27 | 153.08 | 334.2 | Upgrade
|
| Gross Profit | 19.62 | 39.3 | 37.26 | 87.34 | 78.12 | 110.68 | Upgrade
|
| Selling, General & Admin | 16.05 | 22.47 | 29.63 | 34.27 | 33.57 | 33.88 | Upgrade
|
| Other Operating Expenses | 19.15 | 13.74 | 19.07 | 25.28 | 25.4 | 51.74 | Upgrade
|
| Operating Expenses | 39.88 | 40.87 | 52.72 | 63.5 | 63.06 | 89.88 | Upgrade
|
| Operating Income | -20.26 | -1.57 | -15.46 | 23.84 | 15.05 | 20.8 | Upgrade
|
| Interest Expense | -16.6 | -17.94 | -19.77 | -20.91 | -20.85 | -20.57 | Upgrade
|
| Interest & Investment Income | 9.43 | 9.43 | 1.61 | 0.01 | 0.22 | 1.54 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 0.03 | -0.53 | 7.66 | 0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.46 | -0.46 | -0.63 | -0.1 | -0.1 | -0.57 | Upgrade
|
| EBT Excluding Unusual Items | -27.89 | -10.54 | -34.22 | 2.31 | 1.97 | 1.25 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.06 | 0.06 | 0.83 | 0.33 | - | 3.41 | Upgrade
|
| Pretax Income | -27.83 | -10.48 | -33.39 | 2.64 | 1.97 | 4.67 | Upgrade
|
| Income Tax Expense | -1.01 | -0.57 | -0.09 | 0.42 | -0.33 | -0.27 | Upgrade
|
| Earnings From Continuing Operations | -26.82 | -9.92 | -33.31 | 2.22 | 2.3 | 4.93 | Upgrade
|
| Net Income | -26.82 | -9.92 | -33.31 | 2.22 | 2.3 | 4.93 | Upgrade
|
| Net Income to Common | -26.82 | -9.92 | -33.31 | 2.22 | 2.3 | 4.93 | Upgrade
|
| Net Income Growth | - | - | - | -3.26% | -53.38% | 10.63% | Upgrade
|
| Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade
|
| EPS (Basic) | -6.24 | -2.31 | -7.75 | 0.52 | 0.53 | 1.15 | Upgrade
|
| EPS (Diluted) | -6.24 | -2.31 | -7.75 | 0.52 | 0.53 | 1.15 | Upgrade
|
| EPS Growth | - | - | - | -2.42% | -53.78% | 10.63% | Upgrade
|
| Free Cash Flow | - | 17.68 | 30.74 | 14.16 | 33 | -8.99 | Upgrade
|
| Free Cash Flow Per Share | - | 4.11 | 7.15 | 3.29 | 7.67 | -2.09 | Upgrade
|
| Gross Margin | 16.63% | 25.23% | 22.16% | 32.64% | 33.79% | 24.88% | Upgrade
|
| Operating Margin | -17.17% | -1.01% | -9.20% | 8.91% | 6.51% | 4.67% | Upgrade
|
| Profit Margin | -22.73% | -6.37% | -19.81% | 0.83% | 0.99% | 1.11% | Upgrade
|
| Free Cash Flow Margin | - | 11.35% | 18.29% | 5.29% | 14.27% | -2.02% | Upgrade
|
| EBITDA | -16.93 | 1.8 | -12.04 | 27.79 | 19.14 | 25.06 | Upgrade
|
| EBITDA Margin | -14.36% | 1.16% | -7.16% | 10.38% | 8.28% | 5.63% | Upgrade
|
| D&A For EBITDA | 3.32 | 3.37 | 3.42 | 3.95 | 4.09 | 4.26 | Upgrade
|
| EBIT | -20.26 | -1.57 | -15.46 | 23.84 | 15.05 | 20.8 | Upgrade
|
| EBIT Margin | -17.17% | -1.01% | -9.20% | 8.91% | 6.51% | 4.67% | Upgrade
|
| Effective Tax Rate | - | - | - | 15.85% | - | - | Upgrade
|
| Revenue as Reported | 118.17 | 165.51 | 171.3 | 269.19 | 244.12 | 452.93 | Upgrade
|
| Advertising Expenses | - | 0.12 | 0.15 | 0.12 | 0.18 | 0.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.